- Huge primary retroperitoneal mucinous cystadenoma of borderline malignancy mimicking an ovarian mass: Case report and review
[作者:Bifulco, G; Mandato, VD; Giampaolino, P; Nappi, C; De Cecio, R; Insabato, L; Tarsitano, F; Mignogna, C,期刊:Anticancer Research, 页码:2309-2315 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Primary retroperitoneal mucinous cystadenoma: is a rare tumor only 48 cases have been reported in international literature. Patients affected by primary retroperitoneal mucinous cystadenoma/cystadenocarcinoma...
- Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma
[作者:Pectasides, D; Nikolaou, M; Pectasides, E; Koumarianou, A; Valavanis, C; Economopoulos, T,期刊:Anticancer Research, 页码:2317-2320 , 文章类型: Article,,卷期:2008年28-4C]
- The case of a young man with stage IV chemoresistant pure seminoma overexpressing KIT, who achieved complete remission (CR) after the, administration of imatinib mesylate (400 mg once daily), along with a third-line chem...
- CYP1A2 164 A -> C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas
[作者:Saebo, M; Skjelbred, CF; Li, KB; Lothe, IMB; Hagen, PC; Johnsen, E; Tveit, KM; Kure, EH,期刊:Anticancer Research, 页码:2289-2295 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Genetic polymorphisms in metabolizing enzymes may modify the association of environmental exposure on colorectal cancer (CRC) and adenoma risk. Materials and Methods: One hundred and ninety-eight CRC cases, 4...
- Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer
[作者:Shimakawa, T; Naritaka, Y; Asaka, S; Isohata, N; Murayama, M; Konno, S; Yoshimatsu, K; Shiozawa, S; Katsube, T; Ogawa, K,期刊:Anticancer Research, 页码:2321-2326 , 文章类型: Article,,卷期:2008年28-4C]
- This study was performed to assess the usefulness and safety of neoadjuvant chemotherapy utilizing the FAP regimen consisting of 5-fluorouracil, cisplatin and adriamycin for the treatment of highly advanced esophageal ca...
- Weekly irinotecan plus protracted venous fluorouracil infusion (WI-FI) in advanced colorectal cancer: A phase II study
[作者:Oliva, C; Pochettino, P; Bergnolo, P; Boglione, A; Cutin, SC; Ingui, M; Dal Canton, O; Garetto, F; Biscardi, M; Berno, E; Comandone, A,期刊:Anticancer Research, 页码:2327-2332 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Irinotecan (IRI) is a topoisomerase I inhibitor active as first- or second-line chemotherapy in advanced colorectal cancer (ACRC). Its combination with fluorouracil (FU) increases the response rate and prolon...
- Value of serum S-100B for prediction of distant relapse and survival inn stage IIIB/C melanoma
[作者:Smit, LHM; Nieweg, OE; Mooi, WJ; Bonfrer, JMG; Haanen, JBAG; Kroon, BBR; De Gast, GC,期刊:Anticancer Research, 页码:2297-2302 , 文章类型: Article,,卷期:2008年28-4C]
- Background: The biochemical marker serum S-100B has been proven to reflect the stage of melanoma and to be useful for disease monitoring and prediction of survival, mainly in stage IV disease. For stage III melanoma, lim...
- PET-CT in recurrent ovarian cancer: Impact in treatment planning
[作者:Lenhard, MS; Burges, A; Johnson, TRC; Stieber, P; Kumper, C; Ditsch, N; Linke, R; Friese, K,期刊:Anticancer Research, 页码:2303-2308 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Positron emission tomography-computed tomography (PET-CT) is currently not established in the management of recurrent ovarian. cancer. Here, its value in diagnosis and therapy planning was evaluated. Patients...
- Preoperative transvaginal ultrasound (TVS) in the description of pelvic tumor spread in endometrial cancer: Results of a prospective study
[作者:Fotopoulou, C; Sehouli, J; Schefold, JC; Wolf, C; Denkert, C; Lichtenegger, W; Henrich, W,期刊:Anticancer Research, 页码:2453-2458 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Various diagnostic methods are applied preoperatively in patients with suspected and histologically proven endometrial cancer, but no standard diagnostic tool exists for the accurate preoperative evaluation. ...
- Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases
[作者:Neyns, B; Aerts, M; Nieuwenhove, Y; Fontaine, C; De Coster, L; Schallier, D; Vanderauwera, J; De Munck, F; Vandenbroucke, F; Everaert, H; Meert, V; De Mey, J; De Ridder, M; Delvaux, G; De Greve, J,期刊:Anticancer Research, 页码:2459-2467 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Both hepatic arterial infusion (HAI) of chemotherapy and cetuximab (CET) have interesting activity for the treatment of colorectal cancer liver metastases (CRC-LM). Patients and Methods: Intravenous CET with ...
- Expression of NLRP7 (PYPAF3, NALP7) protein in endometrial cancer tissues
[作者:Ohno, S; Kinoshita, T; Ohno, Y; Minamoto, T; Suzuki, N; Inoue, M; Suda, T,期刊:Anticancer Research, 页码:2493-2497 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Nucleotide-binding domain and leucine-rich repeat-containing family, pyrin domain-containing 7 (NLRP7) (pyrin-containing apoptotic protease activating factor-1-like protein 3; PYPAF3, NACHT domain-, leucine-r...
- Nutrient patterns and risk of squamous cell carcinoma of the esophagus: a factor analysis in Uruguay
[作者:De Stefani, E; Boffetta, P; Fagundes, RB; Deneo-Pellegrini, H; Ronco, AL; Acosta, G; Mendilaharsu, M,期刊:Anticancer Research, 页码:2499-2506 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Squamous cell carcinoma of the esophagus is a. common disease, with an age-standardized incidence rate of 55 cases per 700,000 persons in the northern counties of Uruguay. These rates are comparable to those ...
- Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: Clinical and unexpected pharmacokinetic interactions
[作者:Airoldi, M; Cattel, L; Milla, P; Pedani, F; Garzaro, M; Dosio, F,期刊:Anticancer Research, 页码:2519-2527 , 文章类型: Article,,卷期:2008年28-4C]
- Background: The combination of paclitaxel (PTX) with pegylated liposomal doxorubicin (PLD) is an interesting treatment for recurrent head and neck cancer. The pharmacokinetic behavior may depend on the interval between t...
- How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer
[作者:Cordero, OJ; De Chiara, L; Lemos-Gonzalez, Y; De La Cadena, MP; Rodriguez-Berrocal, FJ,期刊:Anticancer Research, 页码:2333-2341 , 文章类型: Review,,卷期:2008年28-4C]
- The number of potential molecular markers is constantly increasing. However, for most malignancies there is no simple test to detect early-stage tumours that is useful for screening purposes because most biomarkers have ...
- Clinical significance and pathogenic function of connective tissue growth factor (CTGF/CCN2) in osteolytic mandibular squamous cell carcinoma
[作者:Shimo, T; Kubota, S; Goda, T; Yoshihama, Y; Kurio, N; Nishida, T; Ng, PS; Endo, K; Takigawa, M; Sasaki, A,期刊:Anticancer Research, 页码:2343-2348 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Mandibular bone destruction is a frequent occurrence in oral squamous cell carcinoma. However, the relationship between the bone destruction and associated factors is unclear. Here, the role and diagnostic ut...
- Craniofacial reconstruction with bone-anchored epithesis in head and neck cancer patients - A valid way back to self-perception and social reintegration
[作者:Wagenblast, J; Baghi, M; Helbig, M; Arnoldner, C; Bisdas, S; Gstottner, W; Hambek, M; May, A,期刊:Anticancer Research, 页码:2349-2352 , 文章类型: Article,,卷期:2008年28-4C]
- Background: Patients with advanced head and neck cancer often require radical and mutilating surgery resulting in severe impairment of their aesthetic self perception and social life. Cosmetically satisfying results asso...
|